🇺🇸 FDA

Intelligence · Patent portfolio

BioMarin Pharmaceutical Australia Patents

Full USPTO pharma patent portfolio for BioMarin Pharmaceutical Australia — grant dates, expiration, and drug cross-links.

Patents
175
Expiring ≤24m
2

Quick answer

BioMarin Pharmaceutical Australia has 175 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 4

  1. US 10646550

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    Expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10563183

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10543237

    Bioeffective krill oil compositions

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10533171

    Oligonucleotide comprising an inosine for treating DMD

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10526346

    Histone deacetylase inhibitors

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10525068

    Anti-inflammatory properties of marine lipid compositions

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10512675

    Adeno-associated virus factor VIII vectors, associated viral particles and therapeutic formulations comprising the same

    Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10463718

    Adeno-associated virus factor VIII vectors

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10456412

    Lipid extraction processes

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10428028

    HDAC inhibitors

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10308608

    Histone deacetylase inhibitors

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10301369

    Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10301323

    Histone deacetylase inhibitors

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10300113

    Targeted therapeutic proteins

    Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10279015

    TPP-1 formulations and methods for treating CLN2 disease

    Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10246707

    Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means

    Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10239832

    N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

    Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10227323

    Glucosylceramide synthase inhibitors for the treatment of diseases

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10227312

    Glucosylceramide synthase inhibitors for the treatment of diseases

    Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10221408

    Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof

    Expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 10179912

    RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 10117882

    Anti-inflammatory properties of marine lipid compositions

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 10105376

    Omega-3 compositions

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10080803

    Emulsified krill phospholipid compositions

    Expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10028968

    Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10029988

    HDAC inhibitors

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10010567

    Bioeffective krill oil compositions

    Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9993481

    Methods and compositions for the treatment of metabolic disorders

    Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9926557

    Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA

    Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9907834

    Use of C-type natriuretic peptide variants to treat skeletal dysplasia

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9908899

    Histone deacetylase inhibitors

    Expires Mon Mar 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9890379

    Treatment of genetic disorders associated with DNA repeat instability

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9889163

    Bioeffective krill oil compositions

    Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9873867

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    Expires Mon Jan 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9867856

    Phospholipid compositions and their preparation

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9845346

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9834588

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9834587

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9816046

    Bioeffective krill oil compositions

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9814762

    Targeted therapeutic proteins

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9796999

    Detection of oligosaccharides

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9796664

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    Expires Mon Oct 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9771408

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9745576

    RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9730966

    Method of reducing appetite in a human subject comprising administering krill oil composition

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9644170

    Bioeffective krill oil compositions

    Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9644169

    Bioeffective krill oil compositions

    Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9572870

    Delivery of therapeutic compounds to the brain and other tissues

    Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does BioMarin Pharmaceutical Australia have?

175 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do BioMarin Pharmaceutical Australia patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.